• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

GlaxoSmithKline's doctor payments double as relaxed policy plays out

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 08, 2021 at 09:23: PM
via GlaxoSmithKline payments to doctors are on the rise again, as its relaxed payment policy continues. It notched a 40% increase from $11 million in 2017 to more than $15 million in 2019 in the U.S., likely reflecting its loosening of a formerly strict physician payment policy.

article source
 




Top Bottom
Back
Quote